Retatrutide is weight loss drug currently being tested to treat obesity and developed by Eli Lilly. Retatrutide works differently to others by targeting three key hormone receptors: GLP-1, GIP, and glucagon. These hormones play a role in gut hormones, insulin production, and blood sugar control.

Early phase 2 trials show extremely encouraging results, with participants experiencing significant weight reduction. While Retatrutide is still under development, it represents a potential new approach to obesity management.

Starts at £0
Please find below product pricing:
Brand Medicine Strength Size Price
- - 1 0.00

It looks like you missed filling in questions from the last consultation.Click Here to submit your response.

Notify me once available

Out of Stock
  • No prescription required
  • Online assessment
  • No hidden fees
You’re almost there!

It is the prescribers duty to ensure that the medicine is being used safely and appropriately. please answer a few questions about yourself to help us process your request.

- Manesha

Customer Service Team

Confidentiality & Authenticity Assured

  • Fully Regulated UK Pharmacy
  • Authentic UK sourced medicines only.
  • Trading for more than 10 years.
  • Information Governance lead ensures all data is confidential

Need Help With Your Questionnaire?

Our customer service team is on hand Monday-Friday to help you with your queries.

Please call us on 08009788956 or
email us at:


UK licenced

100% Discretion
& Confidentiality

Cancel any

Retatrutide: A New Triple Threat Against Weight Loss

Imagine a drug that fights fat by talking to three different messengers in your body at the same time. That's the idea behind Retatrutide, a new medication being tested for obesity. Retatrutide , new weight loss injection acts as a triple agonist peptide targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R), results in reducing the hunger and increasing metabolism simultaneously. This retatrutide injection is still in developmental phase and as soon as it becomes available, you can buy online in Pharmacy planet for the lowest price in the UK as effective weight loss treatment for obesity and diabetes.

Triple Threat vs. Single Focus

Most weight-loss medications target one specific hormone or messenger. Retatrutide is unique because it acts like a triple agent, influencing three hormones (GLP-1, GIP, and glucagon) that play a role in feeling full, blood sugar control, and gut hormones.

Potential for More Powerful Effects

By targeting multiple pathways, Retatrutide might lead to more significant weight loss compared to some existing medications. Early studies back this up, showing promising results in reducing body weight

What is the Average Weight Loss on Retatrutide Injection? 

In Phase 2 trial , participants on retatrutide experienced significant weight loss results. Anyone with BMI of 35 or higher saw a mean weight reduction of 26.5% with the 8-mg dose and 26.4% with the 12-mg dose, compared to 21.3% and 21.5% respectively for those with a lower BMI. Women tended to have a higher mean weight loss than men across both dose groups (28.5% and 26.6% vs. 19.8% and 21.9%). Additionally, after 48 weeks, the trial showed an average weight loss of 24%, with some participants losing more than 30% of their body weight on the highest dose of 12 mg.

Still Under Development

It's important to remember that Retatrutide is in the early stages of testing (like a practice round for a new game). More research is needed to confirm its long-term safety and effectiveness before it becomes widely available.

When will Retatrutide pen be available in Stock in the UK? 

Retatrutide has not yet been approved or released for purchase in the UK. As it is currently in Phase III of testing, and it may take a few years before it becomes available on the market. Therefore, it is not yet accessible for treating conditions such as obesity and type 2 diabetes.

Be the first to know

Sign up to be the first to know when Retrutide becomes available by clicking the 'Notify me once available' button above and enter your email. 

We'll keep you up to date with the latest developments concerning Retatrutide and let you know as soon as it becomes available in the UK.